Research | OneLook Acronym Finder |
Serial Number | 79357621 |
Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
2022-09-14 | Application Filed |
2022-12-16 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
2022-12-16 | Status: Live/Pending |
2022-12-19 | Transaction Date |
Owner: | 1MED SA |
Entity Statement | Società Anonima (SA) |
Address | Via Campagna 13 CH-6982 Agno CH |
Legal Entity Type | |
Legal Entity State | CH |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
260903 | Incomplete squares; Squares, incomplete |
261701 | Bands, straight; Bars, straight; Lines, straight; Straight line(s), band(s) or bar(s) |
261704 | Bands, vertical; Bars, vertical; Lines, vertical; Vertical line(s), band(s) or bar(s) |
261705 | Bands, horizontal; Bars, horizontal; Horizontal line(s), band(s) or bar(s); Lines, horizontal |
International Codes: | 9 |
U.S. Codes: | 021,023,026,036,038 |
International Codes: | 38 |
U.S. Codes: | 100,101,104 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0091 | Software; software and applications for mobile devices; downloadable software applications; specialized software; collaborative software; data communication software; file sharing software; document management software; software for management of data and files and for databases; process control software; data processing software; product lifecycle management software; industrial process management software; software for production process monitoring, analysis, control and operation; software for verification of the regulatory compliance of goods; software for monitoring the regulatory compliance of clinical trials; software for quality control in the field of medical devices and the pharmaceutical industry; software for use in the pharmaceutical and medical device industry for monitoring, analysis, control and operation of the regulatory compliance of manufacturing processes and clinical trials |
Description | Date | Event Coding |
---|---|---|
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2022-12-16 | 1 REPR M: |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2022-12-19 | 2 NWOS I:Incoming Correspondence |
APPLICATION FILING RECEIPT MAILED | 2022-12-23 | 3 MAFR O:Outgoing Correspondence |
ASSIGNED TO EXAMINER | 2023-06-26 | 4 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2023-06-30 | 5 CNRT R:Renewal |
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2023-07-01 | 6 RFCR E:E-Mail |
NEW REPRESENTATIVE AT IB RECEIVED | 2023-07-01 | 7 NREP P: |
REFUSAL PROCESSED BY MPU | 2023-08-07 | 8 RFRR P: |
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2023-08-07 | 9 RFCS P: |
REFUSAL PROCESSED BY IB | 2023-08-29 | 10 RFNT P: |
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2024-02-20 | 11 ABN2 O:Outgoing Correspondence |
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | 2024-02-20 | 12 MAB2 O:Outgoing Correspondence |
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | 2024-02-20 | 13 MAB2 O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.